Reverse engineering, also known as pharmaceutical deformulation, is the process of breaking down an innovator Reference Listed Drug (RLD) to identify its exact qualitative (Q1) and quantitative (Q2) composition. This is a foundational step for successful generic drug product development.
Key Goals of Deformulation Studies
When developing an Abbreviated New Drug Application (ANDA) or generic dossier, matching the innovator's composition reduces clinical trial failures and accelerates regulatory approvals.
Core Analytical Techniques Deployed:
- Extraction & Chromatography (HPLC/UPLC): Quantifying active pharmaceutical ingredients (APIs), preservatives, and solubilizers.
- Thermal Analysis (DSC / TGA): Determining melting points, glass transitions, and moisture content.
- Spectroscopy (FTIR, NMR, Raman): Characterizing polymeric excipients, coatings, and matrix binders.
- X-Ray Powder Diffraction (XRPD): Determining the polymorphic form and crystallinity of the active drug substance.
- Particle Size Analysis & Morphometry: Verifying API particle distribution in suspensions and solid dispersions.
Overcoming Patent and Formulation Hurdles
Understanding the excipient ratios and physical state allows formulators to design around formulation patents while ensuring bioequivalence and stability. KemQuest Pharma Services partners with leading formulation laboratories across India to deliver fast, confidential, and accurate deformulation reports.